Given the continuous changes in the world, with an increasing trend of unhealthy lifestyles,
metabolic comorbidities, and increased susceptibility to cardiovascular diseases (CVDs) …

Aortic valve stenosis is the most common type of heart valve disease in the United States
and Europe and calcific aortic stenosis (AS) affects 2–7% of people aged 65 years and …

To evaluate the association of uric acid (UA) with adverse outcomes and its potential
mediator in patients with left ventricular diastolic dysfunction (LVDD) and pulmonary …

Background and Objectives: Aortic stenosis (AS) is a widespread valvular disease in
developed countries, primarily among the elderly. Transcatheter aortic valve replacement …

Materials and methods: In this retrospective review of 2046 patients who underwent valvular
heart surgery, Cox and LASSO regression analyses were performed to identify independent …

Background One of the hallmarks of frailty in patients with severe aortic stenosis (AS) is
malnutrition, for which one of the most up‐to‐date scoring systems is the Naples prognostic …

Background Neutrophil-to-lymphocyte ratio (NLR) is an easy-to-use inflammatory biomarker.
Baseline NLR is independently associated with incident cardiovascular events and all …

Aims The neutrophil‐to‐lymphocyte ratio (NLR) is a marker of systemic inflammation and
plays a critical role in the assessment and prognosis in patients with heart failure. The EMPA …

Background/Objectives: Advanced calcific aortic stenosis, with or without coronary artery
disease [CAD], may lead to severe systolic dysfunction. The aim of the study was to reveal …

Aim Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) are simple
biomarkers that reflect systemic inflammation and are associated with adverse …